Stockreport

Hoth Therapeutics Announces Issuance of Chinese Patent for Cancer Cell-Targeting Technology [TheStreet.com]

Hoth Therapeutics, Inc.  (HOTH) 
PDF Patent Covers Splice-Switching Oligonucleotide Platform Designed to Induce Apoptosis of Mast Cells NEW YORK March 31, 2026 /PRNewswire/ -- Hoth Therapeutics, Inc. (NA [Read more]